Table 4 Adjusted risk of inappropriate empiric therapy and hospital mortality
Risk of IET in the setting of MDR-AB | Marginal effect, IET in non-MDR-AB | Marginal effect, IET in MDR-AB | Adjusted relative risk ratio (95 % CI) | p Value |
|---|---|---|---|---|
Method | ||||
Parse model | 13.8 % | 76.2 % | 5.5 (4.0–7.7) | < 0.001 |
Propensity score (based on 204 matched pairs; 81.0 % matched) | 13.4 % | 73.9 % | 5.5 (3.6–8.4) | < 0.001 |
Nonparse model | 14.4 % | 75.6 % | 5.3 (3.7–7.4) | < 0.001 |
Risk of death in the setting of IET | Marginal effect, mortality in non-IET | Marginal effect, mortality in IET | Adjusted relative risk ratio (95 % CI) | p Value |
Method | ||||
Parse model | 15.9 % | 24.3 % | 1.53 (1.21–1.93) | < 0.001 |
Propensity score (based on 226 matched pairs; 59.6 % matched) | 15.0 % | 27.8 % | 1.85 (1.35–2.54) | < 0.001 |
Nonparse model | 14.5 % | 25.6 % | 1.76 (1.36–2.28) | < 0.001 |